EV Biotech Secures €4.5M Seed Investment to Supercharge Fermentation Development

Fermentation is the future! EV Biotech offers a solution to the issue of pollution-heavy manufacturing methods by harnessing the power of fermentation combined with state-of-the-art computational methods.

Microbial fermentation allows EV Biotech to work on a greener future while maintaining our current quality of life. It is incredible that something as small as a microorganism has the potential to change our future so drastically. Fermentation processes can be designed to be carbon-neutral, or even carbon-negative through the utilisation of existing industrial waste-streams.

This is in contrast to many traditional production methods, which utilise emission-intensive, fossil fuel-based processes. These methods pollute our environment while trying to meet the demand of our ever growing population. By using unique computational models to equip microorganisms with the right tools, EV Biotech is able to create accelerated microbial production methods. This approach allows us to realise the circular economy dream and reinvent everyday products while replacing pollution-heavy production methods. 

Investeren in een groene toekomst

EV Biotech’s investors acknowledge the change that is needed to achieve the circular economy dream. They have combined their power in this seed round, resulting in an astounding 4.5M investment! This shows confidence in the ability of EV Biotech to achieve their goal of a greener future. The seed round has been led by Future Food Fund, together with NOM, Carduso Capital, Rug Ventures, Triade Investment, Voyagers.io Climate Tech Fund, Blue Horizon, Jogchum Brinksma (Flobas Ventures), Scott Saxberg (Icebook), Hannu Ryopponen, Marc Kaptein, Andrew Nutter and Marie Outtier. 

This seed investment allows EV Biotech to improve existing technology and implement client feedback to improve their products. Furthermore, EV Biotech will continue to develop in-house microorganisms to serve several markets. These funds will allow EV Biotech to pilot their in-house plug and play systems to create a microbial chassis that produces different kinds of bioplastics.

Read the full article via this link.
Source picture: EV Biotech